Clinical use of second-generation antipsychotics in children (vol 5, pg 77, 2017)

被引:0
|
作者
Kakko, Kirsi
Pihlakoski, Leena
Salmelin, Raili
Keskinen, Paivi
Puura, Kaija
Tamminen, Tuula
机构
关键词
D O I
10.21307/sjcapp-2018-008
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:80 / 80
页数:1
相关论文
共 50 条
  • [1] Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
    Ramachandran, Sujith
    Banahan, Benjamin F., III
    Bentley, John P.
    West-Strum, Donna S.
    Patel, Amit S.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2016, 22 (08): : 948 - 957
  • [2] Second-generation antipsychotics in children Risks and monitoring needs
    Lambert, Clare
    Panagiotopoulos, Constadina
    Davidson, Jana
    Goldman, Ran D.
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (09) : 660 - 662
  • [3] Overdoses and ingestions of second-generation antipsychotics in children and adolescents
    Antia, SX
    Sholevar, EH
    Baron, DA
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) : 970 - 985
  • [4] OFF-LABEL USE OF SECOND-GENERATION ANTIPSYCHOTICS
    Spina, Edoardo
    Fava, Giuseppina
    Makos, Xenofon
    CLINICAL NEUROPSYCHIATRY, 2009, 6 (01): : 11 - 20
  • [5] Pharmacogenetics of second-generation antipsychotics
    Brennan, Mark D.
    PHARMACOGENOMICS, 2014, 15 (06) : 869 - 884
  • [6] Concurrent Use of Stimulants and Second-Generation Antipsychotics Among Children With ADHD Enrolled in Medicaid
    Kamble, Pravin
    Chen, Hua
    Johnson, Michael L.
    Bhatara, Vinod
    Aparasu, Rajender R.
    PSYCHIATRIC SERVICES, 2015, 66 (04) : 404 - 410
  • [7] Efficacy and tolerability of second-generation antipsychotics in children and adolescents with schizophrenia
    Kumra, Sanjiv
    Oberstar, Joel V.
    Sikich, Linmarie
    Findling, Robert L.
    McClellan, Jon M.
    Vinogradov, Sophia
    Schulz, S. Charles
    SCHIZOPHRENIA BULLETIN, 2008, 34 (01) : 60 - 71
  • [8] Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children
    Devlin, Angela M.
    Panagiotopoulos, Constadina
    PHARMACOGENOMICS, 2015, 16 (09) : 981 - 996
  • [9] Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia
    Mallinger, JB
    Fisher, SG
    Brown, T
    Lamberti, JS
    PSYCHIATRIC SERVICES, 2006, 57 (01) : 133 - 136
  • [10] Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics
    Joo, Sung Woo
    Lee, Boung Chul
    Lee, Jungsun
    Seo, Gi Hyeon
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2022, 20 (04) : 675 - 684